New York Residents Face Potential Loss of Crucial Health Screening Coverage. A recent budget proposal from New York's state government has sparked concerns among healthcare advocates, who fear that essential biomarker testing coverage may be rolled back. Biomarker testing is a vital diagnostic tool that helps doctors identify genetic mutations and other biomarkers associated with various diseases, allowing for early detection and targeted treatment. If the proposal is implemented, thousands of New Yorkers may lose access to this critical health screening, potentially putting them at risk of delayed or misdiagnosed conditions. As lawmakers debate the budget, healthcare advocates are urging them to reconsider the potential impact on residents' health and well-being.
N.Y. budget proposal could roll back biomarker testing coverage, advocates say cbsnews.com
